Companies Alumis Medical Outcomes Liaison

About the role

Alumis · Onsite

Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients. 

 

The Role

The Medical Outcomes Liaison (MOL) is a field-based Medical Affairs professional responsible for engaging payers and healthcare decision makers (HCDMs). This role focuses on communicating the clinical and economic value of Alumis therapies to support formulary access, reimbursement, and patient outcomes. This is a critical role supporting pre-launch and launch readiness, translating clinical and HEOR evidence into meaningful value narratives for population-based stakeholders.

Key Responsibilities:

• Build and maintain relationships with payers, PBMs, and health systems

• Deliver clinical, real-world, and health economic evidence to inform access decisions

• Support payer engagement strategy, including pre-launch activities and value communication

• Contribute to HEOR and evidence generation plans, including AMCP dossier support

• Gather insights on payer needs and market dynamics to inform strategy

• Collaborate cross-functionally with Medical Affairs, HEOR, and Market Access teams

 

Qualifications:

• Advanced degree required (PharmD, PhD, MD, MPH, or equivalent)

• 5+ years of experience in Medical Affairs, HEOR, Market Access, or related field

• Experience engaging payers or healthcare decision makers strongly preferred

• Strong understanding of HEOR, RWE, and U.S. payer landscape

• Excellent communication and stakeholder engagement skills

 

What You Bring:

• Ability to translate complex data into clear, payer-relevant value insights

• Strong collaboration skills in a cross-functional, fast-paced environment

• Strategic mindset with a focus on value-based care and patient access

Travel: Up to ~50–75%

 

Why Join Alumis

• Be part of a launch-stage biotech shaping the future of TYK2 inhibition

• Play a key role in defining the value story for a novel therapy

• Work in a highly collaborative, science-driven Medical Affairs organization

The salary range for this position is $200,00 to 265,000 USD annually. This salary range is an estimate, and the actual salary may very based on the Company’s compensation practices degree and background.

This position is primarily remote with travel. We have 3 MOL roles (geographically dispersed) that we are working to fill.

 

Alumis Inc. is an equal opportunity employer.

Alumis compensation packages include generous stock option grants for all employees as well as an annual bonus program.  

Other benefits include:

  • Health insurance premiums paid at 90% for employee, 80% for dependents
  • Free access to Genentech Bus & Ferry Share program
  • $100 monthly cell phone stipend
  • Unlimited PTO for Exempt employees
  • Free onsite gym and a kitchen stocked with yummy snacks and drinks!

We are a hard-working, collaborative team on a mission to transform patient’s lives-- and we aspire to elevatechallenge and nurture one another along the way.

Ready to apply to Alumis?
Apply to Alumis

Similar jobs

Sign up for suggestions tailored to the jobs you open and the searches you save.

Apply now
🤖

Whoa — hold up

JobsRadar was built for real people having a rough time in their job search — not for automated requests. You're clicking way too fast and you're now temporarily blocked.

Come back later. If you're genuinely job hunting, we've got your back — just act like a human.

Catch your next role the second it’s posted.

Create a free account and we’ll watch the boards for you — the instant a job matches your search, it lands in your inbox or Telegram. No digging, no refreshing.

Create free account

Free forever · takes 30 seconds · already have one?

Get the worldwide-remote edge.

Join our Telegram channel for the stuff that helps you land the role — salary benchmarks, the weekly market pulse, and new-feature drops. No spam, just signal.

Join the channel — it's free